Mangiferin promotes osteogenic differentiation and alleviates osteoporosis in the ovariectomized mouse <i>via</i> the AXL/ERK5 pathway.

Front Pharmacol · 2022 · PMC9667510 · PMID 36408274

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

Results Mangiferin modulates MC3T3-E1 viability in a dose- and time-dependent manner Among 0, 10, 30, 50, and 100 μM concentrations, the cell viabilities presented an increasing trend from 10 to 30 μM, while it presented a decreasing trend above 30 μM ( Figure 1B ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.